Skip to main content
Top
Published in: Annals of Hematology 10/2018

Open Access 01-10-2018 | Letter to the Editor

A portion of expanded granular lymphocytes cause pure white cell aplasia?

Authors: Yasushi Isobe, Yu Uemura, Akiko Uchida, Ikuo Miura

Published in: Annals of Hematology | Issue 10/2018

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Marinone G, Roncoli B, Marinone MG Jr (1991) Pure white cell aplasia. Semin Hematol 28:298–302PubMed Marinone G, Roncoli B, Marinone MG Jr (1991) Pure white cell aplasia. Semin Hematol 28:298–302PubMed
3.
go back to reference Chan WC, Foucar K, Morice WG, Catovsky D (2017) T-cell large granular lymphocytic leukemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds). WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edn, Vol. 2. IARC Press, Lyon, FR, pp 348–350 Chan WC, Foucar K, Morice WG, Catovsky D (2017) T-cell large granular lymphocytic leukemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds). WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edn, Vol. 2. IARC Press, Lyon, FR, pp 348–350
5.
go back to reference Risitano AM, Selleri C, Serio B, Torelli GF, Kulagin A, Maury S, Halter J, Gupta V, Bacigalupo A, Sociè G, Tichelli A, Schrezenmeier H, Marsh J, Passweg J, Rotoli B, on behalf of the Working Party Severe Aplastic Anaemia (WPSAA) of the European Group for Blood and Marrow Transplantation (EBMT) (2010) Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA. Br J Haematol 148:791–796. https://doi.org/10.1111/j.1365-2141.2009.08027.x CrossRefPubMed Risitano AM, Selleri C, Serio B, Torelli GF, Kulagin A, Maury S, Halter J, Gupta V, Bacigalupo A, Sociè G, Tichelli A, Schrezenmeier H, Marsh J, Passweg J, Rotoli B, on behalf of the Working Party Severe Aplastic Anaemia (WPSAA) of the European Group for Blood and Marrow Transplantation (EBMT) (2010) Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA. Br J Haematol 148:791–796. https://​doi.​org/​10.​1111/​j.​1365-2141.​2009.​08027.​x CrossRefPubMed
Metadata
Title
A portion of expanded granular lymphocytes cause pure white cell aplasia?
Authors
Yasushi Isobe
Yu Uemura
Akiko Uchida
Ikuo Miura
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 10/2018
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3342-5

Other articles of this Issue 10/2018

Annals of Hematology 10/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.